The role of the human NAT1 enzyme in breast cancer has not been extensively explored, although it has previously been demonstrated that the anti-oestrogen compound tamoxifen is an inhibitor of human NAT1 [15–17]. The gene discussed is NAT1; the disease is breast carcinoma.